Animal Antibacterial Peptide Market - Global Forecast 2026-2032

The Animal Antibacterial Peptide Market is projected to reach USD 5.42 Billion in 2026. It is expected to continue growing at a CAGR of 17.68%, reaching USD 14.68 Billion by 2032.

Animal antibacterial peptides, including antimicrobial peptides used in livestock, aquaculture, companion animals, and veterinary biologics research, are gaining strategic relevance as animal health systems respond to antimicrobial resistance, stricter antibiotic stewardship, and rising demand for residue-conscious protein production.

These peptides are short, biologically active molecules that can disrupt microbial membranes, modulate immune responses, and support targeted pathogen control. Their potential value is strongest where conventional antibiotics face regulatory pressure, resistance concerns, or performance limitations. Market interest is supported by global surveillance from the World Health Organization, the World Organisation for Animal Health, and national veterinary agencies, which consistently identify antimicrobial resistance as a One Health risk affecting humans, animals, food systems, and the environment.

Transformative Shifts in the Market Landscape

The landscape for animal antibacterial peptides is being reshaped by antibiotic-reduction policies, precision livestock management, and the shift from therapeutic-only intervention toward preventive animal health. The European Union banned antibiotic growth promoters in 2006, and the United States implemented Veterinary Feed Directive controls to strengthen veterinary oversight of medically important antimicrobials. These policy changes continue to influence global expectations for alternatives.

Commercial development is moving from broad-spectrum substitution to use-case-specific deployment in feed additives, topical veterinary applications, aquaculture disease management, mastitis control research, and companion animal dermatology. Buyers increasingly evaluate efficacy, stability, palatability, delivery format, withdrawal-period implications, and compatibility with probiotics, organic acids, enzymes, vaccines, and biosecurity programs.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accelerating the discovery and optimization of animal antibacterial peptides by enabling high-throughput sequence screening, activity prediction, toxicity modeling, and structure-function analysis. Machine learning models can evaluate peptide charge, hydrophobicity, amphipathicity, molecular weight, and predicted membrane interaction to prioritize candidates before costly wet-lab validation.

AI is also improving formulation and deployment decisions. In animal health, peptide performance depends on species, pathogen load, gut environment, feed processing temperature, delivery route, and microbiome effects. Predictive analytics can help connect farm-level data, veterinary diagnostics, and peptide performance outcomes, supporting more precise use while reducing trial-and-error development cycles.

Key Regional Insights

Asia-Pacific is an important demand center because it combines large livestock populations, aquaculture intensity, and increasing food safety expectations. China, India, Japan, South Korea, Australia, and ASEAN markets are strengthening animal health infrastructure while seeking antibiotic stewardship solutions compatible with high-volume poultry, swine, dairy, and aquaculture production.

North America benefits from advanced veterinary diagnostics, strong animal nutrition capabilities, and established regulatory pathways for veterinary oversight. Latin America, led by Brazil and Mexico, has opportunity tied to poultry, beef, dairy, swine, and export-oriented protein production. Europe remains a regulatory benchmark due to its long-standing restrictions on growth-promoting antibiotics and continued emphasis on antimicrobial reduction, veterinary prescription discipline, and documented responsible use.

The Middle East is developing opportunities through poultry integration, dairy modernization, and food security investment, while Africa presents long-term potential as livestock productivity, veterinary access, cold-chain capacity, and disease prevention programs expand. Across Asia-Pacific, North America, Latin America, Europe, the Middle East, and Africa, adoption depends on local regulatory classification, cost-in-use, evidence quality, manufacturing consistency, and compatibility with existing animal health programs.

Key Economic Group Insights

ASEAN is a relevant growth cluster because poultry, swine, and aquaculture production are central to regional food security, and producers are increasingly attentive to export market standards, residue management, and disease prevention. The GCC is shaped by food import dependence, intensive poultry and dairy projects, and government-backed food security strategies that favor reliable disease-prevention tools suited to controlled production systems.

The European Union remains highly influential for animal antibacterial peptide commercialization because its antimicrobial stewardship framework often sets reference expectations for safety, efficacy, environmental responsibility, and responsible use. BRICS markets combine scale and production diversity, with China, India, Brazil, Russia, and South Africa representing different demand profiles across feed, veterinary, dairy, poultry, swine, and aquaculture applications.

G7 economies contribute advanced research capacity, regulatory science, veterinary diagnostics, and premium animal health purchasing power. NATO countries overlap significantly with high-income veterinary markets, where biosecurity, supply chain resilience, reduced antimicrobial dependence, and preparedness against transboundary animal diseases are increasingly treated as strategic priorities.

Key Country Insights

The United States is supported by sophisticated veterinary oversight, advanced animal health infrastructure, and strong demand for antibiotic alternatives in poultry, swine, dairy, beef, and companion animal care. Canada aligns with similar stewardship objectives and science-based veterinary regulation, while Mexico’s opportunity is linked to integrated poultry, swine, dairy, and export-oriented food production.

Brazil is a major opportunity due to its global role in poultry, beef, and pork exports, while the United Kingdom, Germany, France, Italy, and Spain remain important European markets because of mature veterinary systems, established livestock industries, and pressure to document responsible antimicrobial use. Russia’s demand is influenced by domestic animal protein production, food security priorities, and import substitution dynamics.

China and India represent scale-driven opportunities across livestock and aquaculture, although commercialization depends on regulatory clarity, cost competitiveness, and reliable field evidence. Japan, Australia, and South Korea offer quality-focused markets with advanced veterinary standards, strong biosecurity cultures, and interest in science-backed animal health innovation, particularly where antimicrobial stewardship aligns with food safety and animal welfare objectives.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically relevant efficacy data, species-specific validation, and transparent safety profiles. Peptide candidates should be tested against priority veterinary pathogens, evaluated for resistance-development risk, and benchmarked against existing antibiotics, probiotics, organic acids, enzymes, and vaccination programs.

Companies should invest in formulation technologies that improve stability during feed processing, gastrointestinal transit, topical use, injectable formats, or water delivery. Strategic partnerships with veterinary universities, diagnostic laboratories, feed integrators, and contract research organizations can shorten validation timelines and strengthen technical credibility.

A successful commercialization strategy should include regulatory mapping by country, cost-in-use modeling, scalable manufacturing, quality control, and clear claims management. Firms should also build post-market evidence systems that track performance, antimicrobial reduction outcomes, animal welfare indicators, productivity metrics, and producer return on investment.

Research Methodology

This executive summary is developed using secondary research from recognized public sources, including global One Health guidance, veterinary antimicrobial stewardship frameworks, regulatory agency publications, peer-reviewed scientific literature, animal production databases, and animal health industry reports.

The methodology applies triangulation across regulatory evidence, scientific feasibility, production-system relevance, and commercial adoption indicators. Insights are validated by comparing policy direction, animal production trends, antimicrobial resistance priorities, technology readiness, and regional market conditions. Claims are limited to evidence-supported observations and do not rely on speculative market sizing, market share, or forecasting.

Conclusion and Strategic Outlook

Animal antibacterial peptides are positioned at the intersection of antimicrobial stewardship, precision animal health, and sustainable protein production. Their market relevance is rising as producers and veterinarians seek effective tools that can reduce dependence on conventional antibiotics without compromising animal welfare, productivity, or food safety.

The strongest opportunities will favor organizations that combine peptide science with validated delivery systems, regulatory discipline, AI-enabled discovery, scalable manufacturing, and practical farm-level economics. As resistance concerns and food safety expectations intensify, animal antibacterial peptides can become an important component of integrated disease prevention and responsible animal health management.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Animal Antibacterial Peptide Market, by Product Type

7.1. Introduction
7.2. Naturally Derived Peptide
7.3. Synthetic Peptide
7.3.1. Long Chain
7.3.2. Medium Chain
7.3.3. Short Chain

8. Animal Antibacterial Peptide Market, by Animal Type

8.1. Introduction
8.2. Food-Producing Animals
8.2.1. Cattle
8.2.2. Poultry
8.2.3. Swine
8.3. Companion Animals
8.3.1. Dogs
8.3.2. Cats

9. Animal Antibacterial Peptide Market, by Mode of Delivery

9.1. Introduction
9.2. Oral
9.3. Injectable
9.4. Topical

10. Animal Antibacterial Peptide Market, by Application

10.1. Introduction
10.2. Growth Promotion
10.3. Prophylactic
10.3.1. Disease Prevention
10.3.2. Vaccination Adjuvant
10.4. Therapeutic
10.4.1. Infection Treatment
10.4.2. Skin Disease Treatment

11. Animal Antibacterial Peptide Market, by End User

11.1. Introduction
11.2. Aquaculture Farms
11.3. Feed Manufacturers
11.3.1. Aquafeed
11.3.2. Livestock Feed
11.4. Research Institutes
11.4.1. Academic Institute
11.4.2. Biotech Company
11.5. Veterinary Clinics
11.5.1. Large Animal Practice
11.5.2. Small Animal Practice

12. Animal Antibacterial Peptide Market, by Region

12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa

13. Animal Antibacterial Peptide Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Animal Antibacterial Peptide Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. Competitive Landscape

15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025

16. Company Profiles

16.1. AB Vista Limited
16.2. AgroBioTek Laboratories LLC
16.3. Anitox Corporation
16.4. Biogenesis Bagó S.A.
16.5. Biosynth Ltd
16.6. Boehringer Ingelheim International GmbH
16.7. Cargill, Incorporated
16.8. Dechra Pharmaceuticals PLC
16.9. Eco Animal Health Ltd.
16.10. Elanco Animal Health Incorporated
16.11. Esco Aster Pte. Ltd.
16.12. Genera Inc.
16.13. Huvepharma S.A.
16.14. ImmuCell Corporation
16.15. Kemin Industries, Inc.
16.16. Merck & Co., Inc.
16.17. Neogen Corporation
16.18. Novozymes A/S
16.19. Phibro Animal Health Corporation
16.20. Vetbiochem India Pvt Ltd.
16.21. Vetoquinol S.A.
16.22. Zoetis Inc.
16.23. Zomedica Pharmaceuticals Corp.

List of Figures

FIGURE 1. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

List of Tables

TABLE 1. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL NATURALLY DERIVED PEPTIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL NATURALLY DERIVED PEPTIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL NATURALLY DERIVED PEPTIDE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL SYNTHETIC PEPTIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL SYNTHETIC PEPTIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL SYNTHETIC PEPTIDE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL LONG CHAIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL LONG CHAIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL LONG CHAIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL MEDIUM CHAIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL MEDIUM CHAIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL MEDIUM CHAIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SHORT CHAIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SHORT CHAIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SHORT CHAIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL FOOD-PRODUCING ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL FOOD-PRODUCING ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL FOOD-PRODUCING ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL POULTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SWINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL SWINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL DOGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL DOGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL GROWTH PROMOTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL GROWTH PROMOTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL GROWTH PROMOTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL PROPHYLACTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL PROPHYLACTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL PROPHYLACTIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL DISEASE PREVENTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL DISEASE PREVENTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL DISEASE PREVENTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL VACCINATION ADJUVANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL VACCINATION ADJUVANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL VACCINATION ADJUVANT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL THERAPEUTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL THERAPEUTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL THERAPEUTIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL INFECTION TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL INFECTION TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL INFECTION TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL SKIN DISEASE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL SKIN DISEASE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SKIN DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL FEED MANUFACTURERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL FEED MANUFACTURERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL FEED MANUFACTURERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL AQUAFEED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL AQUAFEED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL AQUAFEED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL LIVESTOCK FEED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL LIVESTOCK FEED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL LIVESTOCK FEED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ACADEMIC INSTITUTE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ACADEMIC INSTITUTE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL ACADEMIC INSTITUTE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL BIOTECH COMPANY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL BIOTECH COMPANY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL BIOTECH COMPANY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL VETERINARY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL VETERINARY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL VETERINARY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL LARGE ANIMAL PRACTICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL LARGE ANIMAL PRACTICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL LARGE ANIMAL PRACTICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL SMALL ANIMAL PRACTICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL SMALL ANIMAL PRACTICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL SMALL ANIMAL PRACTICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 133. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 135. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 136. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 137. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 147. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 148. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 149. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 150. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 151. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 152. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 153. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 154. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 155. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 156. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 157. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 158. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 159. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 160. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 161. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 163. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 164. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 165. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 175. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 176. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 177. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 178. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 179. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 180. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 181. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 182. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 183. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 184. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 185. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 186. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 187. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 188. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 189. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 190. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 191. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 192. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 193. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 194. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 195. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 196. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 197. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 198. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 199. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 200. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 201. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 202. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 203. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 204. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 205. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 206. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 207. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 208. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 209. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 210. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 211. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 212. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 213. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 214. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 215. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 216. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 217. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 232. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 233. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 234. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 235. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 236. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 237. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 238. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 239. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 240. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 241. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 242. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 243. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 244. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 245. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 246. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 247. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 248. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 249. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 250. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 251. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 252. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 253. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 254. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 255. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 256. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 257. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 258. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 259. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 260. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 261. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 262. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 263. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 264. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 265. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 266. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 267. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 268. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 269. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 270. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 271. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 272. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 273. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 274. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 275. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 276. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 277. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 278. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 279. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 280. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 281. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 282. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 283. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 284. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 286. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 289. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 290. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 291. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 292. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 293. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 294. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 295. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 296. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 297. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 298. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 299. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 300. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 301. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 302. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 303. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 304. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 305. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 306. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 307. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 308. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 309. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 310. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 311. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 312. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 313. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 314. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 315. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 316. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 317. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 318. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 319. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 320. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 321. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 322. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 323. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MODE OF DELIVERY, 2017-2032 (USD MILLION)
TABLE 324. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 325. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2017-2032 (USD MILLION)
TABLE 326. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 327. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 328. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2017-2032 (USD MILLION)
TABLE 329. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 330. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2017-2032 (USD MILLION)
TABLE 331. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 332. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 333. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2017-2032 (USD MILLION)
TABLE 334. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 335. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 336. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 337. UNITED KINGDOM ANIMA

Companies Mentioned

AB Vista Limited
AgroBioTek Laboratories LLC
Anitox Corporation
Biogenesis Bagó S.A.
Biosynth Ltd
Boehringer Ingelheim International GmbH
Cargill, Incorporated
Dechra Pharmaceuticals PLC
Eco Animal Health Ltd.
Elanco Animal Health Incorporated
Esco Aster Pte. Ltd.
Genera Inc.
Huvepharma S.A.
ImmuCell Corporation
Kemin Industries, Inc.
Merck & Co., Inc.
Neogen Corporation
Novozymes A/S
Phibro Animal Health Corporation
Vetbiochem India Pvt Ltd.
Vetoquinol S.A.
Zoetis Inc.
Zomedica Pharmaceuticals Corp.

Table Information

Report Attribute	Details
No. of Pages	182
Published	August 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 5.42 Billion
Forecasted Market Value ( USD ) by 2032	$ 14.68 Billion
Compound Annual Growth Rate	17.6%
Regions Covered	Global
No. of Companies Mentioned	23

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3184EUR$3,545USD£2,720GBP €3538EUR$3,939USD£3,022GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4817EUR$5,363USD£4,115GBP €5352EUR$5,959USD£4,572GBP

Transformative Shifts in the Market Landscape

Cumulative Impact of Artificial Intelligence

Key Regional Insights

Key Economic Group Insights

Key Country Insights

Actionable Recommendations for Industry Leaders

Research Methodology

Conclusion and Strategic Outlook

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Animal Health Active Pharmaceutical Ingredients Market - Global Forecast 2026-2032

Veterinary Dermatology Drugs Market Report 2026

Veterinary Antibiotics Market Outlook 2026-2034: Market Share, and Growth Analysis by Animal Type (Poultry, Swine, Cattle, Sheep & Goats, Companion Animals, Aquaculture, Other Livestock), Drug Class, Delivery Form, Spectrum of Activity

Animal Feed Antibiotics Market - Global Forecast 2025-2032

Over-the-Counter (OTC) Veterinary Drugs Market Report 2026